Carregant...
Revisiting PPARγ as a target for the treatment of metabolic disorders
As the prevalence of obesity has increased explosively over the last several decades, associated metabolic disorders, including type 2 diabetes, dyslipidemia, hypertension, and cardiovascular diseases, have been also increased. Thus, new strategies for preventing and treating them are needed. The nu...
Guardat en:
| Publicat a: | BMB Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Society for Biochemistry and Molecular Biology
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4281338/ https://ncbi.nlm.nih.gov/pubmed/25154720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2014.47.11.174 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|